Therapeutic vaccines in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) unfortunately carries a very poor prognosis. Patients usually do not become symptomatic, and therefore do not seek treatment, until the cancer is advanced and it is too late to employ curative treatment options. New therapeutic options are urgently needed for NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Socola, Francisco, Scherfenberg, Naomi, Raez, Luis E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928356/
https://www.ncbi.nlm.nih.gov/pubmed/27471692
http://dx.doi.org/10.2147/ITT.S30813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928356/
https://www.ncbi.nlm.nih.gov/pubmed/27471692
http://dx.doi.org/10.2147/ITT.S30813

Ejemplares similares